Logo-ijhpm
Commentary

1. The Bright Elusive Butterfly of Value in Health Technology Development Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
Trisha Greenhalgh*, Nick Fahy, Sara Shaw
Int J Health Policy Manag. 2018;7(1): 81-85. doi: 10.15171/ijhpm.2017.65
PMCID: PMC5745872     PMID: 29325407    
Article
PDF
XML
Cited By:
Original Article

2. Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Janneke P.C. Grutters* ORCID, Tim Govers ORCID, Jorte Nijboer Nijboer, Marcia Tummers ORCID, Gert Jan van der Wilt ORCID, Maroeska M. Rovers
Int J Health Policy Manag. 2019;8(10): 575-582. doi: 10.15171/ijhpm.2019.36
PMCID: PMC6819627     PMID: 31657184    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Commentary

3. Nurturing Societal Values in and Through Health Innovations Comment on “What Health System Challenges Should Responsible Innovation in Health Address?” 
Payam Abrishami*, Sjoerd Repping ORCID
Int J Health Policy Manag. 2019;8(10): 613-615. doi: 10.15171/ijhpm.2019.57
PMCID: PMC6819623     PMID: 31657189    
Article
PDF
XML
Cited By:
Commentary

4. Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Michael F. Drummond*
Int J Health Policy Manag. 2020;9(6): 260-262. doi: 10.15171/ijhpm.2019.118
PMCID: PMC7382911     PMID: 32613795    
Article
PDF
XML
Cited By: